A 45-year-old man with a history of traumatic brain injury and alcohol use disorder is brought to the emergency department by emergency medical services due to a continuous seizure. Paramedics report the patient has had uninterrupted generalized tonic-clonic movements for the past 18 minutes. He is unresponsive and exhibits continuous rhythmic motor activity of all four extremities. His blood pressure is 152/94 mmHg, heart rate is 128/min, and oxygen saturation is 95% on a non-rebreather mask. Two large-bore peripheral intravenous lines are successfully established.
Arrange the following pharmacologic interventions in the correct protocolized sequence for escalating the management of status epilepticus, starting with the initial first-line therapy.
- 1Administer intravenous lorazepam
- 2Administer intravenous fosphenytoin
- 3Initiate continuous intravenous propofol infusion
- 4Induce intravenous pentobarbital coma
Answer
1. Initial Therapy (First-line): Intravenous lorazepam (or diazepam/midazolam) is the immediate treatment of choice. Benzodiazepines rapidly enhance GABA_A receptor activity to terminate the seizure.
2. Urgent Control Therapy (Second-line): Intravenous fosphenytoin (or valproate/levetiracetam) is administered to achieve sustained seizure control and prevent recurrence, especially if benzodiazepines fail to halt the seizure. Fosphenytoin blocks voltage-gated sodium channels.
3. Refractory Therapy (Third-line): If seizures persist despite first- and second-line agents (refractory status epilepticus), patients require intubation and continuous intravenous anesthetic infusions, such as propofol or midazolam, to suppress cortical electrical activity.
4. Super-Refractory Therapy (Fourth-line): For seizures that persist despite 24 hours of anesthetic infusions, induction of a barbiturate coma (e.g., intravenous pentobarbital) is the final escalation step to achieve profound burst suppression on an electroencephalogram.